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Abstract 
This paper reviews the close connection between unwillingness to donate and a perception that 
organ allocation is driven not by medical need but by ostensibly unfair factors, such as status, 
income, ethnicity, or connections. The lack of organs for transplantation is one of the biggest 
hurdle facing transplantation systems worldwide and transplantation is the only technologically 
advanced field of medicine that is totally dependent on public understanding and support and that 
provides strong reasons to increase transparency and make waiting lists publicly available. 
Keywords: transparency; organ transplant waiting lists; organ donation. 
Resumen 
Este artículo revisa la estrecha relación que ha sido observada entre la negativa a donar órganos 
y la percepción de que los mecanismos de asignación no están, siempre, motivados por la 
necesidades médicas, sino que por factores aparentemente injustos como el estatus, los ingresos, 
el origen étnico o las conexiones. La falta de órganos para trasplante es uno de los mayores 
obstáculos que enfrentan los sistemas de trasplante en todo el mundo y el trasplante es el único 
campo tecnológicamente avanzado de la medicina que depende totalmente de la comprensión y 
el apoyo público, lo que ofrece fuertes razones para aumentar la transparencia y la confianza de 
la comunidad haciendo las listas de espera públicas. 
Palabras clave: transparencia; listas de espera; donación de órganos. 
Resum 
Aquest article revisa l'estreta relació entre la negativa a donar òrgans i la percepció de que els 
mecanismes d'assignació no sempre estan motivats per necessitats mèdiques, sinó per factors 
aparentment injustos com són l'estatus, els ingressos, l'origen ètnic o les connexions individuals. 
La falta d'òrgans per a trasplantaments és un dels majors obstacles que han d’afrontar  els 
sistemes de trasplantament a tot el món i el trasplantament és l'únic camp tecnològicament 
avançat de la medicina que depèn totalment de la comprensió i el suport públic, la qual cosa 
ofereix fortes raons per augmentar-ne la transparència i la confiança de la comunitat fent que les 
llistes d'espera siguin públiques. 
Paraules clau: transparència; llistes d'espera; donació d'òrgans. 
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Introduction 
“Transplantation is the only technologically advanced field of medicine that is totally 
dependent on public understanding and support, for without donors and recipients 
transplantation would simply not exist. Any changes that alter the perceived fairness of 
the system could have an important negative impact”1.  
A lack of organs for transplantation is one of the biggest hurdles facing transplantation systems 
worldwide. In the United Kingdom, every year more than 500 patients died while on the active 
waiting list for an organ transplant2. The gap between the number of persons on the national 
waiting list and the number of available organs increase every year, like the number of people 
dying each year for want of a solid organ transplant3. Every day, 30 U.S. citizens die from the 
failure of a vital organ while still waiting for a suitable transplant, and similar figures ―relative to 
population size― are reported from all of the other developed countries4.  
Options intended to improve organ donation rates have proved insufficient. There is a need 
to focus on innovative solutions and strategies to increase organ donation that are likely to 
succeed in the short to medium term. One alternative is to battle the bad reputation of the system 
due the impact of some trigger events that, from time to time, occur in almost every country in the 
world (as discussed below). This is important because while the extent of opaqueness varies with 
the specific culture and degree of governmental and health legislation development, most motives 
argued to opt out of organ donation can be traced back to myths about critical patients failing to 
receive safe, proper care and mistrust in organ allocation procedures5. 
We know that paucity of information on how waiting lists are managed and limited 
resources allocated is all too common across most fields of medicine. But organ transplantation is 
front and center among areas. We argue here that organ transplantation provides a strong case 
for departing from the right to confidentiality in the form of publicly-accessible waitlists6 designed 
to fight the shortage of organs for transplantation7.  
1. The Issue: Who gets the organ available for transplantation?” 
“There are many frameworks within which organ transplantation can operate, but at the heart of 
any system must be trust… Patients in need of a transplant must be able to trust in an ethical and 
fair organ supply, and that their doctors will provide the highest standards of clinical care”8. In Chile, 
Organs become public goods after being donated for transplantation to be distributed by relevant 
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agencies on behalf of the State. The Organ Donor Act (Law 20413, 2010) established a presumed 
consent system and a transplantation coordinating committee, required the Office of Vital Records 
to keep an official non-donor registry comprising all individuals who opted out. Even though there 
have been several legislative reforms in order to increase organ donation, the shortage remains. 
Why?  
Mistrust in the organ allocation system is the leading motive asserted by opt-outs9. In recent 
years, some high-profile cases (expeditious transplants for interior minister Edmundo Pérez Yoma 
and the wife of health minister Jaime Mañalich) have done little to dispel this perception. Recent 
studies find that nearly 70 percent of respondents are opt-outs, citing an “opaque” organ allocation 
system. Fallout from the above cases, compounded by general mistrust in the system, led to a 
precipitous drop in donation rates 10. 
Transplant centers in the UK are required to meet agreed clinical standards, including these 
patient selection and organ allocation policies11. The criteria for selection and allocation of a donated 
organ must be objective and the reasons evidence-based where possible12. Still, approximately 1000 
people are dying each year on the UK for want of a solid organ transplant13. In these contexts, some 
events that have been an important impact on public perception of organ donation need to be fight 
with transparency. In 1990, Raymond Crockett was found guilty of procuring human organs from 
live donors in exchange for money, as part of a "kidneys for sale" fraud14. 
In the United States there is a legal federal mandate that the allocation system must take into 
account both efficiency and equity15. The United Network for Organ Sharing (UNOS) sets the 
principles for allocation of scarce organs and creates formulas for allocating them. Whenever an 
organ becomes available, a computer generates a priority list among all eligible patients awaiting a 
transplant16. Yet, several conspicuous cases have also put public faith in the allocation system to the 
test. In the nineties, basketball star Mickey Mantle received a swift liver transplant even though his 
kidney failure was alcohol-induced and he had inoperable cancer. As he bypassed over 4,000 others 
on the organ waitlist, charges of favoritism were levelled at the system16. In 1993, Governor Robert 
Casey received a heart-liver transplant in less than a day of going on the list. In 2002, Vice-president 
Dick Cheney received a heart transplant at 65. Recently, Apple co-founder Steve Jobs secured a liver 
transplant posthaste, even though he had terminal cancer and little chance to recover17. 
In 2012 it came to light that some German university hospitals had either manipulated the 
laboratory values of patients on the waiting list or forged hemodialysis data to increase the Model 
for End-stage Liver Disease MELD. There also were accusations of internal non-transparency, as 
other physicians in the same center claimed to have had no knowledge of the data transmitted to 
Eurotransplant18. Organ donation dropped 12.8 percent from a year earlier throughout Germany 
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and reached a record low since 2002. The decline was most noticeable in the second half of 2012, as 
the manipulations of the three transplantation centers became public19. 
Non-transparency in organ allocation fuels skepticism about system fairness, and given the 
close link between public perception and organ donation, bad publicity has an obviously adverse 
impact on the system as a whole20. Research also shows a close connection between unwillingness 
to donate and a strong belief that organ allocation is driven not by medical need but by ostensibly 
unfair factors, such as status, income, ethnicity, or connections21. Donation depends on a positive 
perception of the allocation process.  
2. Organ Allocation: Who decides? 
The lack of transparency in the allocation criteria has fostered community skepticism regarding 
the fairness of the organ allocation process. Organ donation is a field in which public opinion holds 
significant sway22. Public perceptions are often unfavorable, with organ allocation systems 
frequently associated with events suggesting interference by criteria at variance with health 
needs and distributive justice23. In these contexts, the actual strategies to increase the availability 
of organs cannot ignore the need for more transparency. 
The Madrid Resolution and Prospects for Transnational PIAs required governments to 
ensure appropriate access to safe and ethical transplantation with special attention to maximizing 
donation from deceased donors and to protecting the health and welfare of living donor in a 
national self-sufficiency new paradigm24. The trouble with these resolutions lies in expecting 
substantial improvement in donation rates based on the same old standards. Governments are 
asked to enact policies capable of improving self-sufficiency and augment organ availability while 
upholding the WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation, which 
make guarantees of increased system transparency contingent on the rule that “the anonymity of 
donors and recipients be maintained”25. In our view, it is difficult to maximize donation while 
maintaining the same anonymity rules.  
Principle 11 of the WHO Guiding Principles on Human Cell, Tissue and Organ 
Transplantation requires the organization and execution of donation and transplantation 
activities, as well as their clinical results, to be transparent and open to scrutiny, while ensuring 
that the personal anonymity and privacy of donors and recipients are always protected. The WHO 
feels that the transparency requirement “is not inconsistent with shielding from public access 
information that could identify individual donors or recipients”25. But as noted, the research tells 
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a different story. Even if “the necessity of traceability” is upheld, the fact of the matter is that the 
opt-outs we wish to turn into opt-ins (if present rates are to improve) lack the tools needed to 
know why a certain person received an organ. What’s more, even individuals on organ waiting 
lists express reasonable doubt about the fairness of allocation decisions26. 
Confidentiality runs counter to a patient’s interest in receiving the best care possible27. To 
such patients, best care means obtaining a new organ. Inasmuch as mistrust in allocation systems 
directly impacts availability of organs for transplantation28 bringing waitlists into the open should 
afford patients a chance to more closely monitor the procedure while encouraging others to trust 
the system and consider becoming donors. We argue here that organ transplantation provides a 
strong case for publicly-accessible waitlists29. 
In cases such as organ allocation, confidentiality may clash with a patient’s interest in 
receiving the best care possible. “Allocation rules, defined by appropriately constituted 
committees, should be equitable, externally justified, and transparent”, Guiding Principle 925. Yet, 
transparency and accountability demands cannot be met solely by ensuring that “every step in the 
allocation process is documented and can be explained”30. 
Reinstalling confidence in the system requires a complete overhaul of allocation 
mechanisms, ensuring a transparent process across the board and public involvement in setting 
the criteria that will ultimately determine who stays alive. What really matters is to provide, as 
needed, the ability to track waitlist progress, the criteria under which a given patient is allocated 
an organ, and where waiting relatives, friends or acquaintances stand. In this line, the discussion 
should focus on what are the best mechanisms to ensure full transparency of the system or organs 
allocation. 
3. Discussion: A Public Waiting List? 
In general, the goal of all these allocation systems is to harmonize and articulate justice as well as 
utility, at last, in three factors: present need, urgency and efficiency. However, the integration of 
these goals into a single formula is a formidable task that no current system has really achieved. The 
reason why it is not enough to just explain patients about the selection criteria of the waiting list is 
that transparency's aim must continue throughout the process. Patients have the right to know why 
they have not been chosen yet for transplantation. Especially if certain disrepute events have 
undermined the public perception of fairness.  
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To be sure, the general principles of distributive justice cannot address critical rationing 
issues through decisions leaving no room for divergence. Real transparency requires parsing the 
value-based issues often passing for clinical judgement. As such, a fair process requires according 
individuals the ability and tools to challenge medical decisions ―including, first and foremost, 
information―. Studies show that knowing “who received an organ, and why” is a crucial 
requirement not met by merely reporting a procedural result. Stakeholders should have the ability 
to know exactly who is on the list, how the process is unfolding, how the rules previously determined 
by all were applied, and if concerns arise, to contest decisions28. At present, health systems lack 
mechanisms ensuring transparency ―in general, not just on issues of transplantation31―.  
Surely, some fear that bringing allocation criteria and procedures into the open could 
compromise the perception of “rationality” of the allocation systems because most of the systems 
cannot really integrate in a singular formula all of the goals that a fair and efficient allocation system 
needs to aim “integrating these goals into a single formula is a formidable task”16. But if patients are 
to accept the limitations imposed by organ shortages, they need tools to commit to these compelling 
reasons as well as clear grounds to dispute them. That is why transparency is so important. The 
transparency imperative cover many ideas: (i) transparency of allocation algorithm (which is 
publicly available for some current systems), (ii) transparency of waiting lists (which encompasses 
removal of anonymity), (iii) public involvement in modeling allocation algorithm and (iv) ability of 
potential recipients to challenge allocation decisions31. We claim that all of these elements must be 
public access. Therefore, the discussion from now on should not be whether to be fully transparent, 
but which are the best mechanisms to ensure such transparency.  
The reason why it is not enough to just explain patients about the selection criteria of the 
waiting list is that transparency's aim must continue throughout the process. Patients have the right 
to know why they have not been chosen yet for transplantation. Reinstalling confidence in the 
system requires a complete overhaul of allocation mechanisms, ensuring a transparent process 
across the board and public involvement in setting the criteria that will ultimately determine who 
stays alive (particularly because the allocation criteria usually have not been agreed with the 
community involvement)33. What really matters is to provide, as needed, the ability to track waitlist 
progress and the criteria under which a given patient is allocated an organ32. 
There are many factors that influence the increase of organ donation rates, including potential 
donor availability, transplantation infrastructure, health care spending and public attitudes, as well 
as familial consent and donor registries. Nevertheless, without transparency, open discussion and 
appealable decision-making, organ donation rates will not improve substantially. Too much is at 
stake not to commit to a concerted effort to overhaul system design. Unless the rules change, results 
will stay the same. 
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